A PHP Error was encountered

Severity: Notice

Message: Only variable references should be returned by reference

Filename: core/Common.php

Line Number: 257

A PHP Error was encountered

Severity: Warning

Message: Cannot modify header information - headers already sent by (output started at /home/biomagaz/cwcms_core/system/core/Exceptions.php:185)

Filename: core/Security.php

Line Number: 188

A PHP Error was encountered

Severity: Warning

Message: Cannot modify header information - headers already sent by (output started at /home/biomagaz/cwcms_core/system/core/Exceptions.php:185)

Filename: libraries/Session.php

Line Number: 672

BIO Magazine - Neovasc Inc, To present at BioFinance 2012 Conference Δεκέμβριος 2015
Δεκέμβριος 2015 No38

BIO Finance

Neovasc Inc, To present at BioFinance 2012 Conference
Neovasc Inc, To present at BioFinance 2012 Conference

May 24, 2012 - Vancouver, BC, Canada - Neovasc Inc. (TSXV: NVC), a developer of novel technologies to treat vascular disease, today announced that the company will present at the BioFinance 2012 Conference on May 30, 2012 at 2:00 pm EDT. The conference will be held at the St. Andrew's Club & Conference Centre in Toronto, Canada. Neovasc management will provide an overview of recent company developments. 


An updated corporate presentation that includes the material presented during the BioFinance 2012 presentation will be posted on the Neovasc website at the time of the session on May 30, 2012, at www.neovasc.com/investors/presentations.php. 


About BioFinance 2012
BioFinance 2012 is the leading investor conference in Canada for the life sciences industry. This event brings together key industry players interested in investment opportunities and issues affecting companies in the life sciences sector. Presenting companies span a range of industries including: biologics, medical devices, drug delivery, vaccines, diagnostics, bio-energy, green technologies, bio materials, industrial biotech, and research services. BioFinance 2012 will be held on May 29 and 30, 2012, at St. Andrew's Club & Conference Centre in Toronto. For more information, visit
http://www.biofinance.ca


About Neovasc Inc.
Neovasc Inc. is a specialty medical device company that develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products include the Neovasc Reducer™ for the treatment of refractory angina, the Tiara™ technology in development for the transcatheter treatment of mitral valve disease and a line of advanced biological tissue products that are used as key components in a variety of third-party medical products, such as vascular surgical patches and transcatheter heart valves. For more information, visit: www.neovasc.com.

 

Corporate Contact:
Neosvac Inc., Chris Clark, 604 248-4138

 

U.S. Media & Investor Contact:
BLL Partners, LLC, Barbara Lindheim, 212 584-2276
blindheim@bllbiopartners.com 


 

<< Επιστροφή στην λίστα

© BIO | info@biomagazine.gr

Powered by CreativeWorks